Advanced strategies in liposomal cancer therapy: Problems and prospects of active and tumor specific drug release

Andresen, Thomas L.; Jensen, Simon S.; Jørgensen, Kent

doi:10.1016/j.plipres.2004.12.001

Cited by 580Nanoparticle-Based Drug DeliveryRNA Interference and Gene DeliveryUltrasound and Hyperthermia Applications

Advanced strategies in liposomal cancer therapy: Problems and prospects of active and tumor specific drug release

Andresen, Thomas L., Jensen, Simon S., Jørgensen, Kent·2005·Progress in Lipid Research

DOI 10.1016/j.plipres.2004.12.001

Open this paper in CoChat — free account

Abstract

Tumor specific drug delivery has become increasingly interesting in cancer therapy, as the use of chemotherapeutics is often limited due to severe side effects. Conventional drug delivery systems have shown low efficiency and a continuous search for more advanced drug delivery principles is therefore of great importance. In the first part of this review, we present current strategies in the drug delivery field, focusing on site-specific triggered drug release from liposomes in cancerous tissue. Currently marketed drug delivery systems lack the ability to actively release the carried drug and rely on passive diffusion or slow non-specific degradation of the liposomal carrier. To obtain elevated tumor-to-normal tissue drug ratios, it is important to develop drug delivery strategies where the liposomal carriers are actively degraded specifically in the tumor tissue. Many promising strategies have emerged ranging from externally triggered light- and thermosensitive liposomes to receptor targeted, pH- and enzymatically triggered liposomes relying on an endogenous trigger mechanism in the cancerous tissue. However, even though several of these strategies were introduced three decades ago, none of them have yet led to marketed drugs and are still far from achieving this goal. The most advanced and prospective technologies are probably the prodrug strategies where non-toxic drugs are carried and activated specifically in the malignant tissue by overexpressed enzymes. In the second part of this paper, we review our own work, exploiting secretory phospholipase A2 as a site-specific trigger and prodrug activator in cancer therapy. We present novel prodrug lipids together with biophysical investigations of liposome systems, constituted by these new lipids and demonstrate their degradability by secretory phospholipase A2. We furthermore give examples of the biological performance of the enzymatically degradable liposomes as advanced drug delivery systems.

Integrity signals

Registry

Crossref · 10.1016/j.plipres.2004.12.001

Cites

260 of 260 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Dendrimers are one of the important classes of drug carriers and operate by encapsulating drugs in their unique macromolecular architecture.
“Dendrimers are one of the important classes of drug carriers and operate by encapsulating drugs in their unique macromolecular architecture.242”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [242]

Poly(N-isopropylacrylamide): experiment, theory and application
Schild, H. G. (1992) · Progress in Polymer Science · doi:10.1016/0079-6700(92)90023-r · Cited by 5,162 · see citing works
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552 · see citing works
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438 · see citing works
Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents.
Ohkuma, S., & Poole, B. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.7.3327 · Cited by 2,185 · see citing works
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
Arap, W., Pasqualini, R., & Ruoslahti, E. I. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,040 · see citing works
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
Klibanov, A. L., Maruyama, K., Torchilin, V. P., & Huang, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81016-h · Cited by 2,030 · see citing works
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., & Jain, R. K. (1995) · PubMed · Cited by 1,706 · see citing works
Pharmacokinetics of Pegylated Liposomal Doxorubicin
Gabizón, A., Shmeeda, H., & Barenholz, Y. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342050-00002 · Cited by 1,639 · see citing works
Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation
Helmlinger, G., Yuan, F., Dellian, M., & Jain, R. K. (1997) · Nature Medicine · doi:10.1038/nm0297-177 · Cited by 1,629 · see citing works
Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.
Papahadjopoulos, D., Allen, T. M., Gabizón, A., Mayhew, E. G., Matthay, K. K., Huang, S. K., Lee, K. D., Woodle, M. C., Lasiç, D. D., & Redemann, C. T. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11460 · Cited by 1,621 · see citing works
Drug delivery strategy utilizing conjugation via reversible disulfide linkages: Role and site of cellular reducing activities
Saito, G., Swanson, J. A., & Lee, K.-D. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00179-5 · Cited by 1,407 · see citing works
Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo
Allen, T. M., Hansen, C., Martin, F., Redemann, C. T., & Yau‐Young, A. O. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90246-5 · Cited by 1,392 · see citing works
Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes.
Gabizón, A., Catane, R., Uziely, B., Kaufman, B., Safra, T., Cohen, R., Martin, F., Huang, A., & Barenholz, Y. (1994) · PubMed · Cited by 1,382 · see citing works
The expanding superfamily of phospholipase A2 enzymes: classification and characterization
Six, D. A., & Dennis, E. A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00105-0 · Cited by 1,359 · see citing works
Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors
Drummond, D. C., Meyer, O., Hong, K., Kirpotin, D. B., & Papahadjopoulos, D. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01426-1 · Cited by 1,265 · see citing works
Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties
Moghimi, S. M., & Szebeni, J. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00033-x · Cited by 1,228 · see citing works
Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.
Gabizón, A., & Papahadjopoulos, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6949 · Cited by 1,134 · see citing works
Effect of comonomer hydrophilicity and ionization on the lower critical solution temperature of N-isopropylacrylamide copolymers
Feil, H., Bae, Y. H., Feijén, J., & Kim, S. W. (1993) · Macromolecules · doi:10.1021/ma00062a016 · Cited by 1,074 · see citing works
Sterically stabilized liposomes
Woodle, M. C., & Lasiç, D. D. (1992) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(92)90038-c · Cited by 1,018 · see citing works
Phase transitions in phospholipid vesicles Fluorescence polarization and permeability measurements concerning the effect of temperature and cholesterol
Papahadjopoulos, D., Jacobson, K., Nir, S., & Isac, I. (1973) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(73)90314-3 · Cited by 998 · see citing works
Design of Liposomes for Enhanced Local Release of Drugs by Hyperthermia
Yatvin, M. B., Weinstein, J. N., Dennis, W. H., & Blumenthal, R. P. (1978) · Science · doi:10.1126/science.364652 · Cited by 959 · see citing works
Folate-mediated delivery of macromolecular anticancer therapeutic agents
Lu, Y. J., & Low, P. S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00042-x · Cited by 942 · see citing works
Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases.
Haran, G., Cohen, R., Bar, L. K., & Barenholz, Y. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90105-9 · Cited by 934 · see citing works
Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft.
Yuan, F., Leunig, M., Huang, S. K., Berk, D. A., Papahadjopoulos, D., & Jain, R. K. (1994) · PubMed · Cited by 908 · see citing works
Tumor Regression by Targeted Gene Delivery to the Neovasculature
Hood, J. D., Bednarski, M. D., Frausto, R. F., Guccione, S., Reisfeld, R. A., Xiang, R., & Cheresh, D. A. (2002) · Science · doi:10.1126/science.1070200 · Cited by 858 · see citing works
The promise of retinoids to fight against cancer
Altucci, L., & Gronemeyer, H. (2001) · Nature Reviews Cancer · doi:10.1038/35106036 · Cited by 773 · see citing works
Phospholipase A2 enzymes
Kudo, I., & Murakami, M. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00020-5 · Cited by 757 · see citing works
A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model.
Needham, D., Anyarambhatla, G., Kong, G., & Dewhirst, M. W. (2000) · PubMed · Cited by 746 · see citing works
Large unilamellar liposomes with low uptake into the reticuloendothelial system
Allen, T. M., & Chonn, A. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)80506-9 · Cited by 729 · see citing works
Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody
Yuan, F., Chen, Y., Dellian, M., Safabakhsh, N., Ferrara, N., & Jain, R. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14765 · Cited by 719 · see citing works
Interfacial Catalysis: the Mechanism of Phospholipase A 2
Scott, D. L., White, S. P., Otwinowski, Z., Yuan, W., Gelb, M. H., & Sigler, P. B. (1990) · Science · doi:10.1126/science.2274785 · Cited by 709 · see citing works
Liposomes for the sustained drug release in vivo
Blume, G., & Cevc, G. (1990) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(90)90440-y · Cited by 701 · see citing works
Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis.
Lee, R., & Low, P. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41848-5 · Cited by 694 · see citing works
Rapid acidification of endocytic vesicles containing α2-macroglobulin
Tycko, B., & Maxfield, F. R. (1982) · Cell · doi:10.1016/0092-8674(82)90219-7 · Cited by 673 · see citing works
Liposome application: problems and prospects.
Barenholz, Y. (2001) · Current Opinion in Colloid & Interface Science · doi:10.1016/s1359-0294(00)00090-x · Cited by 659 · see citing works
Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
Park, J. W., Hong, K., Kirpotin, D. B., Colbern, G. T., Shalaby, R., Baselga, J. M., Shao, Y. Y., Nielsen, U. B., Marks, J. D., Moore, D. H., et al. (2002) · PubMed · Cited by 647 · see citing works
Fate and behavior of liposomes in vivo: a review of controlling factors.
Senior, J. H. (1987) · PubMed · Cited by 592 · see citing works
Tumoritropic and lymphotropic principles of macromolecular drugs.
Maeda, H., & Matsumura, Y. (1989) · PubMed · Cited by 579 · see citing works
Cyclopentenone prostaglandins: New insights on biological activities and cellular targets
Straus, D. S., & Glass, C. K. (2001) · Medicinal Research Reviews · doi:10.1002/med.1006 · Cited by 575 · see citing works
Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro
Lee, R. J., & Low, P. S. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)00235-h · Cited by 575 · see citing works
Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes.
Harrington, K. J., Mohammadtaghi, S., Uster, P. S., Glass, D. M., Peters, A. M., Vile, R. G., & Stewart, J. S. W. (2001) · PubMed · Cited by 575 · see citing works
The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors
Needham, D., & Dewhirst, M. W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00233-2 · Cited by 572 · see citing works
Pegylated Liposomal Doxorubicin: Metamorphosis of an Old Drug into a New Form of Chemotherapy
Gabizón, A. (2001) · Cancer Investigation · doi:10.1081/cnv-100103136 · Cited by 569 · see citing works
Endophilin I mediates synaptic vesicle formation by transfer of arachidonate to lysophosphatidic acid
Schmidt, A., Wolde, M., Thiele, C., Fest, W., Kratzin, H., Podtelejnikov, A. V., Witke, W., Huttner, W. Β., & Söling, H. (1999) · Nature · doi:10.1038/43613 · Cited by 533 · see citing works
Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: Studies with poly(ethylene glycol)-coated vesicles
Senior, J. H., Delgado, C., Fisher, D., Tilcock, C., & Gregoriadis, G. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90337-8 · Cited by 521 · see citing works
Cyclopentenone prostaglandins: New insights on biological activities and cellular targets
Straus, D. S., & Glass, C. K. (2001) · Medicinal Research Reviews · doi:10.1002/med.1006.abs · Cited by 521 · see citing works
Phospholipase A2
Murakami, M., & Kudo, I. (2002) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a003101 · Cited by 509 · see citing works
Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
Kong, G., Anyarambhatla, G., Petros, W. P., Braun, R. D., Colvin, O. M., Needham, D., & Dewhirst, M. W. (2000) · PubMed · Cited by 505 · see citing works
Drug Delivery and Transport to Solid Tumors
Jang, S. H., Wientjes, M. G., Lü, D., & Au, J. L. ‐. (2003) · Pharmaceutical Research · doi:10.1023/a:1025785505977 · Cited by 491 · see citing works
Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil®): possible role in hypersensitivity reactions
Chanan-Khan, A., Szebeni, J., Savay, S., Liebes, L., Rafique, N. M., Alving, C. R., & Muggia, F. M. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg374 · Cited by 479 · see citing works
Current status of pH-sensitive liposomes in drug delivery
Drummond, D. C., Zignani, M., & Leroux, J. (2000) · Progress in Lipid Research · doi:10.1016/s0163-7827(00)00011-4 · Cited by 478 · see citing works
Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.
Uziely, B., Jeffers, S., Isacson, R., Kutsch, K., Wei‐Tsao, D. D., Yehoshua, Z., Libson, E., Muggia, F. M., & Gabizón, A. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.7.1777 · Cited by 477 · see citing works
Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid–PEG conjugates
Gabizon, A. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.011 · Cited by 464 · see citing works
Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes.
Chonn, A., Semple, S. C., & Cullis, P. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37026-7 · Cited by 461 · see citing works
pH-Induced destabilization of phosphatidylethanolamine-containing liposomes: role of bilayer contact
Ellens, H. M., Bentz, J., & Szoka, F. C. (1984) · Biochemistry · doi:10.1021/bi00302a029 · Cited by 442 · see citing works
Sterically Stabilized Anti-HER2 Immunoliposomes: Design and Targeting to Human Breast Cancer Cells in Vitro
Kirpotin, D. B., Park, J. W., Hong, K., et al. (1997) · Biochemistry · doi:10.1021/bi962148u · Cited by 440 · see citing works
Ligand-targeted liposomal anticancer drugs
Sapra, P., & Allen, T. M. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00032-8 · Cited by 438 · see citing works
Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism.
Helmlinger, G., Sckell, A., Dellian, M., Forbes, N. S., & Jain, R. K. (2002) · PubMed · Cited by 420 · see citing works
p H-Sensitive Liposomes: Possible Clinical Implications
Yatvin, M. B., Kreutz, W., Horwitz, B. A., & Shinitzky, M. (1980) · Science · doi:10.1126/science.7434025 · Cited by 415 · see citing works
Looking at lipid rafts?
Jacobson, K., & Dietrich, C. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01495-0 · Cited by 413 · see citing works
Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response
Crowl, R. M., Stoller, T. J., Conroy, R. R., & Stoner, C. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52293-6 · Cited by 409 · see citing works
Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.
Goren, D., Horowitz, A. T., Tzemach, D., Tarshish, M., Zalipsky, S., & Gabizón, A. (2000) · PubMed · Cited by 402 · see citing works
DRUG-CARRIER POTENTIAL OF LIPOSOMES IN CANCER CHEMOTHERAPY
Gregoriadis, G., Swain, C. P., Wills, E. J., & Tavill, A. S. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90682-5 · Cited by 400 · see citing works
Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma
Judson, I. R., Radford, J. A., Harris, M., Blay, J., van Hoesel, Q., Cesne, A. L., van Oosterom, A. T., Clemons, M. J., Kamby, C., Hermans, C., et al. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00050-8 · Cited by 392 · see citing works
Do sterols reduce proton and sodium leaks through lipid bilayers?
Haines, T. H. (2001) · Progress in Lipid Research · doi:10.1016/s0163-7827(01)00009-1 · Cited by 387 · see citing works
YELLOW NAILS AND LYMPHOEDEMA.
Hiscock, C., & ISDALE, I. C. (1964) · PubMed · Cited by 370 · see citing works
Phosphatodylethanolamine liposomes: drug delivery, gene transfer and immunodiagnostic applications
Litzinger, D. C., & Huang, L. (1992) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(92)90039-d · Cited by 368 · see citing works
Liposomes and Local Hyperthermia: Selective Delivery of Methotrexate to Heated Tumors
Weinstein, J. N., Magin, R. L., Yatvin, M. B., & Zaharko, D. S. (1979) · Science · doi:10.1126/science.432641 · Cited by 363 · see citing works
Interfacial Enzymology: The Secreted Phospholipase A2-Paradigm
Berg, O. G., Gelb, M. H., Tsai, M., et al. (2001) · Chemical Reviews · doi:10.1021/cr990139w · Cited by 350 · see citing works
In Vitro Gene Delivery to Hepatocytes with Galactosylated Polyethylenimine
Zanta, M.-A., Boussif, O., Adib, A., & Behr, J. (1997) · Bioconjugate Chemistry · doi:10.1021/bc970098f · Cited by 339 · see citing works
Tumor targeting using anti-her2 immunoliposomes
Park, J. W., Kirpotin, D. B., Hong, K., Shalaby, R., Shao, Y., Nielsen, U. B., Marks, J. D., Papahadjopoulos, D., & Benz, C. C. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00315-7 · Cited by 335 · see citing works
Passive tumor targeting of soluble macromolecules and drug conjugates.
Seymour, L. W. (1992) · PubMed · Cited by 316 · see citing works
Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin
Schiffelers, R. M. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00240-2 · Cited by 307 · see citing works
Controlled targeting of liposomal doxorubicin via the folate receptor in vitro
Saul, J. M., Annapragada, A., Natarajan, J. V., & Bellamkonda, R. V. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00295-5 · Cited by 303 · see citing works
Thermosensitive polymer-modified liposomes
Kono, K. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00204-6 · Cited by 303 · see citing works
Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial.
Ranson, M., Carmichael, J., O'Byrne, K. J., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.10.3185 · Cited by 294 · see citing works
A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells
Allen, T. M., Brandeis, E., Hansen, C. B., Kao, G. Y., & Zalipsky, S. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)00085-h · Cited by 288 · see citing works
pH-sensitive liposomes: acid-induced liposome fusion.
Connor, J., Yatvin, M. B., & Huang, L. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.6.1715 · Cited by 288 · see citing works
Liposomen
Allen, T. M. (1997) · Drugs · doi:10.2165/00003495-199700544-00004 · Cited by 279 · see citing works
Review Hyperthermia and liposomes
Kong, M.-Q. (1999) · International Journal of Hyperthermia · doi:10.1080/026567399285558 · Cited by 277 · see citing works
Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma.
Huang, S. K., Mayhew, E. G., Gilani, S., Lasiç, D. D., Martin, F. J., & Papahadjopoulos, D. (1992) · PubMed · Cited by 274 · see citing works
Thermosensitive liposomes: Extravasation and release of contents in tumor microvascular networks
Gaber, M. H., Wu, N. Z., Hong, K., Huang, S. K., Dewhirst, M. W., & Papahadjopoulos, D. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00389-6 · Cited by 271 · see citing works
Thermal Properties of Copolymer Gels Containing N-Isopropylacrylamide
Shibayama, M., Mizutani, S.-Y., & Nomura, S. (1996) · Macromolecules · doi:10.1021/ma951390q · Cited by 267 · see citing works
Roles of lipid polymorphism in intracellular delivery
Hafez, I. M., & Cullis, P. R. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00103-x · Cited by 267 · see citing works
Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol) s conjugated at their distal terminals to monoclonal antibodies
Maruyama, K., 知子, 滝., Yuda, T., Kennel, S. J., Huang, L., & Iwatsuru, M. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)00263-o · Cited by 265 · see citing works
Tumor angiogenesis and accessibility: Role of vascular endothelial growth factor
JAIN, R. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70063-8 · Cited by 256 · see citing works
Phototriggering of liposomal drug delivery systems
Shum, P., Kim, J.-M., & Thompson, D. H. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00232-0 · Cited by 255 · see citing works
Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer
Matsumura, Y., Gotoh, M., Muro, K., Yamada, Y., Shirao, K., Shimada, Y., Okuwa, M., Matsumoto, S., Miyata, Y., Ohkura, H., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh092 · Cited by 253 · see citing works
Lipid vesicles and membrane fusion
Cevc, G., & Richardsen, H. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00030-7 · Cited by 251 · see citing works
Cytosolic drug delivery using pH- and light-sensitive liposomes
Gerasimov, O. V., Boomer, J. A., Qualls, M. M., & Thompson, D. H. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00035-6 · Cited by 246 · see citing works
Tumor angiogenesis and accessibility: Role of vascular endothelial growth factor
Jain, R. K. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.37265 · Cited by 243 · see citing works
Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: a stage toward artificial viruses.
Rémy, J.-S., Kichler, A., Mordvinov, V. A., et al. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1744 · Cited by 241 · see citing works
Stealth liposomes and tumor targeting: one step further in the quest for the magic bullet.
Gabizón, A. (2001) · PubMed · Cited by 236 · see citing works
Sterically Stabilized pH-sensitive Liposomes, INTRACELLULAR DELIVERY OF AQUEOUS CONTENTS AND PROLONGED CIRCULATION IN VIVO
Slepushkin, V., Simões, S., Dazin, P. F., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.4.2382 · Cited by 235 · see citing works
Steric Stabilization of Fusogenic Liposomes by a Low-pH Sensitive PEG−Diortho Ester−Lipid Conjugate
Guo, X. D., & Szoka, F. C. (2001) · Bioconjugate Chemistry · doi:10.1021/bc000110v · Cited by 233 · see citing works
Quantitation and physiological characterization of angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment.
Dellian, M., Witwer, B. P., Salehi, H. A., Yuan, F., & Jain, R. K. (1996) · Europe PMC (PubMed Central) · Cited by 232 · see citing works
PANCREATITIS INDUCED BY 5-AMINOSALICYLIC ACID
Deprez, P. H., Descamps, C., & Fiasse, R. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90620-x · Cited by 231 · see citing works
Non-bilayer lipids and biological fusion intermediates
Chernomordik, L. (1996) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(96)02583-2 · Cited by 220 · see citing works
Thermally and Photochemically Triggered Self-Assembly of Peptide Hydrogels
Collier, J. H., Hu, B., Ruberti, J. W., et al. (2001) · Journal of the American Chemical Society · doi:10.1021/ja011535a · Cited by 219 · see citing works
Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells
Ishida, T., Kirchmeier, M. J., Moase, E. H., Zalipsky, S., & Allen, T. M. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00409-6 · Cited by 216 · see citing works
ROLE OF COMPLEMENT ACTIVATION IN HYPERSENSITIVITY REACTIONS TO DOXIL AND HYNIC PEG LIPOSOMES: EXPERIMENTAL AND CLINICAL STUDIES
Szebeni, J., Baranyi, L., Sávay, S., Milosevits, J., Bünger, R., Laverman, P., Metselaar, J. M., Storm, G., Chanan-Khan, A. A., Liebes, L., et al. (2002) · Journal of Liposome Research · doi:10.1081/lpr-120004790 · Cited by 212 · see citing works
Possibility of active targeting to tumor tissues with liposomes
Maruyama, K., Ishida, O., 知子, 滝., & Moribe, K. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00042-3 · Cited by 211 · see citing works
Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG–lipids
Shin, J. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00232-3 · Cited by 209 · see citing works
Thermosensitive Sterically Stabilized Liposomes: Formulation and in Vitro Studies on Mechanism of Doxorubicin Release by Bovine Serum and Human Plasma
Gaber, M. H., Hong, K., Huang, S. K., & Papahadjopoulos, D. (1995) · Pharmaceutical Research · doi:10.1023/a:1016206631006 · Cited by 206 · see citing works
Proton-induced fusion of oleic acid-phosphatidylethanolamine liposomes
Düzgüneş, N., Straubinger, R. M., Baldwin, P. A., Friend, D. S., & Papahadjopoulos, D. (1985) · Biochemistry · doi:10.1021/bi00334a004 · Cited by 206 · see citing works
Liposomes with detachable polymer coating: destabilization and fusion of dioleoylphosphatidylethanolamine vesicles triggered by cleavage of surface‐grafted poly(ethylene glycol)
Kirpotin, D. B., Hong, K., Mullah, N. N., Papahadjopoulos, D., & Zalipsky, S. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00521-2 · Cited by 206 · see citing works
Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes
Harding, J. A., Engbers, C. M., Newman, M. S., Goldstein, N. I., & Zalipsky, S. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00056-4 · Cited by 202 · see citing works
Strategy for the treatment of acute myelogenous leukemia based on folate receptor β–targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid
Pan, X. Q., Zheng, X., Shi, G., Wang, H., Ratnam, M., & Lee, R. J. (2002) · Blood · doi:10.1182/blood.v100.2.594 · Cited by 199 · see citing works
High-Generation Polycationic Dendrimers Are Unusually Effective at Disrupting Anionic Vesicles: Membrane Bending Model
Zhang, Z., & Smith, B. D. (2000) · Bioconjugate Chemistry · doi:10.1021/bc000018z · Cited by 199 · see citing works
Folate-Targeted PEG as a Potential Carrier for Carboplatin Analogs. Synthesis and in Vitro Studies
Aronov, O., Horowitz, A. T., Gabizon, A., & Gibson, D. (2003) · Bioconjugate Chemistry · doi:10.1021/bc025642l · Cited by 198 · see citing works
New Detachable Poly(ethylene glycol) Conjugates: Cysteine-Cleavable Lipopolymers Regenerating Natural Phospholipid, Diacyl Phosphatidylethanolamine
Zalipsky, S., Qazen, M. M., Walker, J. A., Mullah, N. N., Quinn, Y. P., & Huang, S. K. (1999) · Bioconjugate Chemistry · doi:10.1021/bc990031n · Cited by 198 · see citing works
Endocytosis of liposomes by macrophages: binding, acidification and leakage of liposomes monitored by a new fluorescence assay
Daleke, D. L., Hong, K., & Papahadjopoulos, D. (1990) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(90)90365-u · Cited by 194 · see citing works
Systematic Relationship between Phospholipase A2 Activity and Dynamic Lipid Bilayer Microheterogeneity
Hønger, T., Jørgensen, K., Biltonen, R. L., et al. (1996) · Biochemistry · doi:10.1021/bi960866a · Cited by 189 · see citing works
Self-citation
Delivery of molecular and cellular medicine to solid tumors
Jain, R. K. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00237-x · Cited by 186 · see citing works
Efficiency of Cytoplasmic Delivery by pH-Sensitive Liposomes to Cells in Culture
Chu, C.-J., Dijkstra, J., Lai, M., Hong, K., & Szoka, F. C. (1990) · Pharmaceutical Research · doi:10.1023/a:1015908831507 · Cited by 184 · see citing works
Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis
Leung, S. Y., Chen, X., Chu, K., Yuen, S. T., Mathy, J. A., Ji, J., Chan, A. S. Y., Li, R., Law, S. Y.-K., Troyanskaya, O. G., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212646299 · Cited by 183 · see citing works
Phase I–II study of pegylated liposomal cisplatin (SPI-077™) in patients with inoperable head and neck cancer
Harrington, K. J., Lewanski, C. R., Northcote, A. D., et al. (2001) · Annals of Oncology · doi:10.1023/a:1011199028318 · Cited by 182 · see citing works
Folate-Liposome-Mediated Antisense Oligodeoxynucleotide Targeting to Cancer Cells: Evaluation in Vitro and in Vivo
Leamon, C. P., Cooper, S. R., & Hardee, G. E. (2003) · Bioconjugate Chemistry · doi:10.1021/bc020089t · Cited by 181 · see citing works
Structure and Catalytic Mechanism of Secretory Phospholipases A2
Scott, D. L., & Sigler, P. B. (1994) · Advances in protein chemistry · doi:10.1016/s0065-3233(08)60638-5 · Cited by 173 · see citing works
Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospects
Lü, Y. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00215-3 · Cited by 172 · see citing works
Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction
Szebeni, J., Baranyi, L., Sávay, S., Bodo, M., Morse, D. S., Bašta, M., Stahl, G. L., Bünger, R., & Alving, C. R. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.3.h1319 · Cited by 172 · see citing works
Phase II Trial of the Pegylated Liposomal Doxorubicin in Previously Treated Metastatic Endometrial Cancer: A Gynecologic Oncology Group Study
Muggia, F. M., Blessing, J. A., Sorosky, J. I., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.171 · Cited by 167 · see citing works
Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma
Zamboni, W. C., Gervais, A. C., Egorin, M. J., Schellens, J. H. M., Zuhowski, E. G., Pluim, D., Joseph, E., Hamburger, D. R., Working, P. K., Colbern, G. T., et al. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0719-4 · Cited by 166 · see citing works
Enzyme-activated targeting of liposomes
Meers, P. R. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00205-8 · Cited by 160 · see citing works
A New Look at Lipid-Membrane Structure in Relation to Drug Research
Mouritsen, O. G., & Jørgensen, K. (1998) · Pharmaceutical Research · doi:10.1023/a:1011986613392 · Cited by 159 · see citing works
Self-citation
Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine.
Allen, T. M., Mehra, T., Hansen, C., & Chin, Y. C. (1992) · PubMed · Cited by 159 · see citing works
Expression of Group IIA Secretory Phospholipase A2 Is Elevated in Prostatic Intraepithelial Neoplasia and Adenocarcinoma
Jiang, J., Neubauer, B. L., Graff, J. R., et al. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64886-9 · Cited by 159 · see citing works
Enzymatic Release of Antitumor Ether Lipids by Specific Phospholipase A2Activation of Liposome-Forming Prodrugs
Andresen, T. L., Davidsen, J. R., Begtrup, M., Mouritsen, O. G., & Jørgensen, K. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm031029r · Cited by 158 · see citing works
Self-citation
Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo
COLLINS, P. D., Connolly, D. T., & Williams, T. J. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13553.x · Cited by 156 · see citing works
Diplasmenylcholine−Folate Liposomes: An Efficient Vehicle for Intracellular Drug Delivery
Rui, Y., Wang, S. S., Low, P. S., et al. (1998) · Journal of the American Chemical Society · doi:10.1021/ja9742949 · Cited by 150 · see citing works
Group-Specific Assays That Distinguish between the Four Major Types of Mammalian Phospholipase A2
Yang, H., Mosior, M. K., Johnson, C. A., Chen, Y., & Dennis, E. A. (1999) · Analytical Biochemistry · doi:10.1006/abio.1999.4053 · Cited by 150 · see citing works
Enhanced delivery of doxorubicin to tumor by long-circulating thermosensitive liposomes and local hyperthermia
Maruyama, K., Unezaki, S., Takahashi, N., & Iwatsuru, M. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90203-c · Cited by 140 · see citing works
Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor models
Bandak, S., Goren, D., Horowitz, A. T., et al. (1999) · Anti-Cancer Drugs · doi:10.1097/00001813-199911000-00007 · Cited by 138 · see citing works
Secreted phospholipase A2 as a new enzymatic trigger mechanism for localised liposomal drug release and absorption in diseased tissue
Davidsen, J. R., Jørgensen, K., Andresen, T. L., & Mouritsen, O. G. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(02)00659-4 · Cited by 138 · see citing works
Self-citation
Expression of group IIa secretory phospholipase A2 increases with prostate tumor grade.
Graff, J. R., Konicek, B. W., Deddens, J. A., Chedid, M., Hurst, B. M., Colligan, B. M., Neubauer, B. L., Carter, H. W., & Carter, J. H. (2001) · PubMed · Cited by 136 · see citing works
A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer
Kim, E. S., Lu, C., Khuri, F. R., et al. (2001) · Lung Cancer · doi:10.1016/s0169-5002(01)00278-1 · Cited by 135 · see citing works
Hyperthermic treatment of malignant diseases: current status and a view toward the future.
Dewhirst, M. W., Prosnitz, L. R., Thrall, D. Ε., Prescott, D., Clegg, S., Charles, C., MacFall, J. R., Rosner, G., Samulski, T. V., Gillette, E. L., et al. (1997) · PubMed · Cited by 135 · see citing works
Thermosensitive polymer-modified liposomes that release contents around physiological temperature
Kono, K., Nakai, R., Morimoto, K., & Takagishi, T. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00226-0 · Cited by 133 · see citing works
Cytoplasmic delivery of calcein mediated by liposomes modified with a pH-sensitive poly(ethylene glycol) derivative
Kono, K., Igawa, T., & Takagishi, T. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(96)00244-1 · Cited by 130 · see citing works
Triggerable plasmalogen liposomes: improvement of system efficiency
Thompson, D. H., Gerasimov, O. V., Wheeler, J. J., et al. (1996) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)00210-3 · Cited by 127 · see citing works
Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin
Terwogt, J. M. M., Groenewegen, G., Pluim, D., Maliepaard, M., Tibben, M. M., Huisman, A., Huinink, W. W. T. B., Schot, M. E., Welbank, H., Voest, E. E., et al. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800100371 · Cited by 124 · see citing works
Phospholipase A2 expression in tumours: a target for therapeutic intervention?
Laye, J. P., & Gill, J. H. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02754-5 · Cited by 124 · see citing works
Anionic phospholipids, interfacial binding and the regulation of cell functions
Buckland, A. G., & Wilton, D. C. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00188-2 · Cited by 124 · see citing works
Multiple Injections of Pegylated Liposomal Doxorubicin: Pharmacokinetics and Therapeutic Activity
Charrois, G. J. R., & Allen, T. M. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.053413 · Cited by 124 · see citing works
Kinetics of interfacial catalysis by phospholipase A2 in intravesicle scooting mode, and heterofusion of anionic and zwitterionic vesicles
Jain, M. K., Rogers, J. M., Jahagirdar, D. V., et al. (1986) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(86)90541-9 · Cited by 121 · see citing works
Biology of Human Alkaline Phosphatases with Special Reference to Cancer
Millán, J. L., Fishman, W. H., & Stinson, R. A. (1995) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408369509084680 · Cited by 118 · see citing works
Small-scale lipid-membrane structure: simulation versus experiment
Mouritsen, O. G., & Jørgensen, K. (1997) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(97)80116-9 · Cited by 118 · see citing works
Self-citation
Triggered release of hydrophilic agents from plasmologen liposomes using visible light or acid
Anderson, V. C., & Thompson, D. H. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90183-m · Cited by 117 · see citing works
Biophysical mechanisms of phospholipase A2 activation and their use in liposome‐based drug delivery
Jørgensen, K., Davidsen, J. R., & Mouritsen, O. G. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03408-7 · Cited by 116 · see citing works
Self-citation
Mechanism of pH-Triggered Collapse of Phosphatidylethanolamine Liposomes Stabilized by an Ortho Ester Polyethyleneglycol Lipid
Guo, X. D., MacKay, J. A., & Szoka, F. C. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)74986-8 · Cited by 116 · see citing works
Antitumor Activity of Folate Receptor-Targeted Liposomal Doxorubicin in a KB Oral Carcinoma Murine Xenograft Model
Pan, X. Q., Wang, H., & Lee, R. J. (2003) · Pharmaceutical Research · doi:10.1023/a:1022656105022 · Cited by 115 · see citing works
Characterization of In Vivo Immunoliposome Targeting to Pulmonary Endothelium
Maruyama, K., Holmberg, E. G., Kennel, S. J., Klibanov, A. L., Torchilin, V. P., & Huang, L. (1990) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600791107 · Cited by 110 · see citing works
Novel pH-sensitive liposomes: liposomes bearing a poly(ethylene glycol) derivative with carboxyl groups
Kono, K., Zenitani, K.-I., & Takagishi, T. (1994) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)90325-5 · Cited by 108 · see citing works
Lag-burst kinetics in phospholipase A2 hydrolysis of DPPC bilayers visualized by atomic force microscopy
Nielsen, L. K., Risbo, J., Callisen, T. H., et al. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00103-0 · Cited by 106 · see citing works
Effects of Polyethyleneglycol Chain Length and Phospholipid Acyl Chain Composition on the Interaction of Polyethyleneglycol-phospholipid Conjugates with Phospholipid: Implications in Liposomal Drug Delivery
Bedu-Addo, F. K., Tang, P. S., Xu, Y., & Huang, L. (1996) · Pharmaceutical Research · doi:10.1023/a:1016091314940 · Cited by 105 · see citing works
Copolymers of N‐isopropylacrylamide can trigger pH sensitivity to stable liposomes
Meyer, O., Papahadjopoulos, D., & Leroux, J. (1998) · FEBS Letters · doi:10.1016/s0014-5793(97)01520-2 · Cited by 105 · see citing works
Arrest of human lung tumor xenograft growth in severe combined immunodeficient mice using doxorubicin encapsulated in sterically stabilized liposomes.
Williams, S. S., Alosco, T., Mayhew, E. S., et al. (1993) · PubMed · Cited by 104 · see citing works
Docosahexaenoic acid induces apoptosis in Jurkat cells by a protein phosphatase-mediated process
Siddiqui, R. A., Jenski, L. J., Neff, K., Harvey, K. A., Kovacs, R. J., & Stillwell, W. H. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(00)00128-2 · Cited by 104 · see citing works
Wavelength-Programmed Solute Release from Photosensitive Liposomes
Bisby, R. H., Mead, C., & Morgan, C. G. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3456 · Cited by 104 · see citing works
Tumour uptake of doxorubicin in polyethylene glycol-coated liposomes and therapeutic effect against a xenografted human pancreatic carcinoma
Vaage, J., Donovan, D., Uster, P. S., & Working, P. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.84 · Cited by 104 · see citing works
Fluctuations caught in the act
Nielsen, L. K., Bjørnholm, T., & Mouritsen, O. G. (2000) · Nature · doi:10.1038/35006162 · Cited by 102 · see citing works
Immune clearance of liposomes inhibited by an anti-Fc receptor antibody in vivo.
Aragnol, D., & Leserman, L. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2699 · Cited by 101 · see citing works
Interaction of Hydrophobically‐Modified Poly‐N‐isopropylacrylamides with Model Membranes—or Playing a Molecular Accordion
Ringsdorf, H., Venzmer, J., & Winnik, F. M. (1991) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199103151 · Cited by 101 · see citing works
Liposome Longevity and Stability in Circulation: Effects on the in vivo Delivery to Tumors and Therapeutic Efficacy of Encapsulated Anthracyclines
Gabizón, A., Chemla, M., Tzemach, D., et al. (1996) · Journal of drug targeting · doi:10.3109/10611869608996830 · Cited by 100 · see citing works
Structural and functional comparisons of pH-sensitive liposomes composed of phosphatidylethanolamine and three different diacylsuccinylglycerols
Collins, D. S., Litzinger, D. C., & Huang, L. (1990) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(90)90102-t · Cited by 99 · see citing works
Inhibition of phospholipase A2 as a therapeutic target
Yedgar, S., Lichtenberg, D. A., & Schnitzer, E. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00120-7 · Cited by 98 · see citing works
Analogs of alkyllysophospholipids: Chemistry, effects on the molecular level and their consequences for normal and malignant cells
Brachwitz, H., & Vollgraf, C. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)00001-w · Cited by 97 · see citing works
Uptake and processing of immunoglobulin-coated liposomes by subpopulations of rat liver macrophages
DERKSEN, J. T. P., Morselt, H. W. M., & Scherphof, G. L. (1988) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(88)90184-x · Cited by 97 · see citing works
Pharmaco attributes of dioleoylphosphatidylethanolamine/cholesterylhemisuccinate liposomes containing different types of cleavable lipopolymers
Zhang, J. X. (2003) · Pharmacological Research · doi:10.1016/j.phrs.2003.09.003 · Cited by 95 · see citing works
Nanometre-scale structure of fluid lipid membranes
Nielsen, L. K., Vishnyakov, A., Jørgensen, K., et al. (2000) · Journal of Physics Condensed Matter · doi:10.1088/0953-8984/12/8a/340 · Cited by 94 · see citing works
Self-citation
The electrostatic basis for the interfacial binding of secretory phospholipases A2
Scott, D. L., Mandel, A., Sigler, P. B., et al. (1994) · Biophysical Journal · doi:10.1016/s0006-3495(94)80546-6 · Cited by 94 · see citing works
A Two-Photon View of an Enzyme at Work: Crotalus atrox Venom PLA2 Interaction with Single-Lipid and Mixed-Lipid Giant Unilamellar Vesicles
Sánchez, S. A., Bagatolli, L. A., Gratton, E., et al. (2002) · Biophysical Journal · doi:10.1016/s0006-3495(02)75569-0 · Cited by 94 · see citing works
STEALTH liposome-encapsulated cisplatin (SPI-77) versus carboplatin as adjuvant therapy for spontaneously arising osteosarcoma (OSA) in the dog: a randomized multicenter clinical trial
Vail, D. M., Kurzman, I. D., Glawe, P., O’Brien, M. G., Chun, R., Garrett, L. D., Obradovich, J. E., Fred, R. M., Khanna, C., Colbern, G. T., et al. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-002-0469-8 · Cited by 91 · see citing works
Visible-Light-Stimulated Destabilization of PEG-Liposomes
Mueller, A., Bondurant, B., & O’Brien, D. F. (2000) · Macromolecules · doi:10.1021/ma000055l · Cited by 90 · see citing works
Interactions between pH-sensitive liposomes and model membranes
Bergstrand, N., Arfvidsson, M. C., Kim, J.-M., et al. (2003) · Biophysical Chemistry · doi:10.1016/s0301-4622(03)00011-5 · Cited by 87 · see citing works
Fluorescence ratio imaging of interstitial pH in solid tumours: effect of glucose on spatial and temporal gradients
Dellian, M., Helmlinger, G., Yuan, F., et al. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.518 · Cited by 85 · see citing works
Liposomes as a carrier for intracellular delivery of antisense oligonucleotides: a real or magic bullet?
Zelphati, O., & Szoka, F. C. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(96)01361-2 · Cited by 85 · see citing works
Photoinitiated destabilization of sterically stabilized liposomes
Bondurant, B., Mueller, A., & O’Brien, D. F. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00388-6 · Cited by 84 · see citing works
[21] Kinetic basis for interfacial catalysis by phospholipase A2
Jain, M. K., Gelb, M. H., Rogers, J. M., et al. (1995) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(95)49049-3 · Cited by 84 · see citing works
Miltefosine as a topical treatment for cutaneous metastases in breast carcinoma
Clive, S., Gardiner, J., & Léonard, R. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051114 · Cited by 81 · see citing works
Photoinduced destabilization of liposomes
Lamparski, H. G., Liman, U., Barry, J., et al. (1992) · Biochemistry · doi:10.1021/bi00118a008 · Cited by 81 · see citing works
Characterization of sterically stabilized cisplatin liposomes by nuclear magnetic resonance
Peleg‐Shulman, T., Gibson, D., Cohen, R., Abra, R. M., & Barenholz, Y. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00359-x · Cited by 80 · see citing works
Structural Aspects of Interfacial Adsorption
Han, S. K., Yoon, E. T., Scott, D. L., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3573 · Cited by 79 · see citing works
Vesicle Membrane Fusion Induced by the Concerted Activities of Sphingomyelinase and Phospholipase C
Ruiz-Argüello, M. B., Goñi, F. M., & Alonso, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.36.22977 · Cited by 78 · see citing works
Effect of poly(ethylene glycol) grafts on temperature-sensitivity of thermosensitive polymer-modified liposomes
Kono, K., Yoshino, K., & Takagishi, T. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00018-4 · Cited by 77 · see citing works
Active Uptake of Drugs into Photosensitive Liposomes and Rapid Release on UV Photolysis ¶
Bisby, R. H., Mead, C., & Morgan, C. G. (2000) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2000)0720057auodip2.0.co2 · Cited by 77 · see citing works
Overexpression of the nonpancreatic secretory group II PLA2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients.
Kennedy, B. P., Soravia, C., Moffat, J., Xia, L., Hiruki, T., Collins, S., Gallinger, S., & Bapat, B. V. (1998) · PubMed · Cited by 77 · see citing works
Synergistic permeability enhancing effect of lysophospholipids and fatty acids on lipid membranes
Davidsen, J. R., Mouritsen, O. G., & Jørgensen, K. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(02)00461-3 · Cited by 75 · see citing works
Self-citation
Cholesterol Phosphate Derivatives: Synthesis and Incorporation into a Phosphatase and Calcium-Sensitive Triggered Release Liposome
Davis, S., & Szoka, F. C. (1998) · Bioconjugate Chemistry · doi:10.1021/bc980047y · Cited by 75 · see citing works
Elevation of serum group II phospholipase A2 levels in patients with advanced cancer
Yamashita, S., Ogawa, M., Sakamoto, K., Abe, T., Arakawa, H., & Yamashita, J. (1994) · Clinica Chimica Acta · doi:10.1016/0009-8981(94)90280-1 · Cited by 74 · see citing works
A phase II study of Doxil (liposomal doxorubicin): Lack of activity in poor prognosis soft tissue sarcomas
García, A. A., Kempf, R. A., Rogers, M., et al. (1998) · Annals of Oncology · doi:10.1023/a:1008439013169 · Cited by 71 · see citing works
Comparative neurotoxicity of oxaliplatin, ormaplatin, and their biotransformation products utilizing a rat dorsal root ganglia in vitro explant culture model
Luo, F., Wyrick, S. D., & Chaney, S. G. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050941 · Cited by 69 · see citing works
A phase I study in paediatric patients to evaluate the safety and pharmacokinetics of SPI-77, a liposome encapsulated formulation of cisplatin
Veal, G. J., Griffin, M. J., Price, E., Parry, A., Dick, G., Little, M., Yule, S. M., Morland, B. J., Estlin, E., Hale, J., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1723 · Cited by 69 · see citing works
Comparative study of the antitumor activity of free doxorubicin and polyethylene glycol-coated liposomal doxorubicin in a mouse lymphoma model.
Cabanes, A., Tzemach, D., Goren, D., et al. (1998) · PubMed · Cited by 68 · see citing works
Triggerable liposomal fusion by enzyme cleavage of a novel peptide–lipid conjugate
Pak, C. C., Ali, S., Janoff, A. S., et al. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00041-8 · Cited by 66 · see citing works
Phase II study of pegylated liposomal doxorubicin (Caelyx™) as induction chemotherapy for patients with squamous cell cancer of the head and neck
Harrington, K. J., Lewanski, C. R., Northcote, A. D., Whittaker, J., Peters, A. M., Vile, R. G., & Stewart, J. S. W. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00216-7 · Cited by 65 · see citing works
Targeted Delivery of Doxorubicin via Sterically Stabilized Immunoliposomes: Pharmacokinetics and Biodistribution in Tumor-bearing Mice
Emanuel, N., Kedar, E., Bolotin, E. M., Smorodinsky, N. I., & Barenholz, Y. (1996) · Pharmaceutical Research · doi:10.1023/a:1016096910822 · Cited by 64 · see citing works
Cytotoxic Etherphospholipid Analogues
Berkovic, D. (1998) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(98)00081-0 · Cited by 64 · see citing works
Antitumor ether lipids and alkylphosphocholines
Lohmeyer, M., & Bittman, R. (1994) · Drugs of the Future · doi:10.1358/dof.1994.019.11.595800 · Cited by 64 · see citing works
Changes in Vesicle Morphology Induced by Lateral Phase Separation Modulate Phospholipase A2 Activity
Burack, R., Dibble, A. R. G., Allietta, M. M., et al. (1997) · Biochemistry · doi:10.1021/bi970509f · Cited by 62 · see citing works

Flagged first, then by citations

Sorted by citations

Lipid NanoparticlesFrom Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement
Tenchov, R., Bird, R., Curtze, A. E., & Zhou, Q. (2021) · ACS Nano · doi:10.1021/acsnano.1c04996 · Cited by 2,221 · see citing works
New developments in liposomal drug delivery
Pattni, B. S., Chupin, V. V., & Torchilin, V. P. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00046 · Cited by 1,600 · see citing works
Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review
Hossen, S., Hossain, M. K., Basher, M. K., Mia, M. N. H., Rahman, M. T., & Uddin, M. J. (2019) · Journal of Advanced Research · doi:10.1016/j.jare.2018.06.005 · Cited by 998 · see citing works
Enzyme-responsive nanoparticles for drug release and diagnostics
de la Rica, R., Aili, D., & Stevens, M. M. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.01.002 · Cited by 765 · see citing works
Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles
Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645 · see citing works
Light‐sensitive Intelligent Drug Delivery Systems<sup>†</sup>
Alvarez‐Lorenzo, C., Bromberg, L., & Concheiro, A. (2009) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2008.00530.x · Cited by 519 · see citing works
pH-sensitive biomaterials for drug delivery
Zhuo, S., Zhang, F., Yu, J., Zhang, X., Yang, G., & Liu, X. (2020) · Molecules · doi:10.3390/molecules25235649 · Cited by 247 · see citing works
Liposome imaging agents in personalized medicine
Petersen, A. L., Hansen, A. E., Gabizon, A., & Andresen, T. L. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.003 · Cited by 164 · see citing works
Self-citation
Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line.
Markoutsa, E., Pampalakis, G., Niarakis, A., Romero, I. A., Weksler, B., Couraud, P.-O., & Antimisiaris, S. G. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.11.015 · Cited by 122 · see citing works
Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor region
Amin, M., Mansourian, M., Koning, G. A., Badiee, A., Jaafari, M. R., & ten Hagen, T. L. M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.039 · Cited by 83 · see citing works
Liposomal Drug Delivery
Allison, S. D. (2007) · Journal of Infusion Nursing · doi:10.1097/01.nan.0000264712.26219.67 · Cited by 45 · see citing works
Enhanced Growth Inhibition of Osteosarcoma by Cytotoxic Polymerized Liposomal Nanoparticles Targeting the Alcam Cell Surface Receptor
Federman, N., Chan, J., Nagy, J. O., Landaw, E. M., McCabe, K., Wu, A. M., Triche, T., Kang, H., Liu, B., Marks, J. D., et al. (2012) · Sarcoma · doi:10.1155/2012/126906 · Cited by 44 · see citing works

Nanoparticle-mediated Drug Delivery Systems (DDS) in the Central Nervous System
Zhang, G., Chen, L., Guo, X., et al. (2016) · Current Organic Chemistry · doi:10.2174/1385272820666161017170325 · Cited by 6 · see citing works
pH-responsive anticancer drug delivery systems: Insights into the enhanced adsorption and release of DOX drugs using graphene oxide as a nanocarrier
Le, Q. H., Neila, F., Smida, K., et al. (2023) · Engineering Analysis with Boundary Elements · doi:10.1016/j.enganabound.2023.09.008 · Cited by 55 · see citing works
Application of liposomes as carriers of anti-tumor drugs
Wei-jin, C. (2009) · Zhongguo xin yao zazhi
Vesicular Phospholipid Gels
Brandl, M., & Massing, U. (2003) · doi:10.1093/oso/9780199636556.003.0014 · Cited by 7 · see citing works
Liposomal sustained-release delivery systems for intravenous injection. II. Design of liposome carriers and blood disposition of lipophilic mitomycin C prodrug-bearing liposomes.
Tokunaga, Y., IWASA, T., Fujisaki, J., et al. (1988) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.36.3557 · Cited by 21 · see citing works

Authors: Andresen, T. L., Jensen, S. S., & Jørgensen, K.
Affiliations: Technical University of Denmark (DK)
Corresponding author: Andresen, Thomas L.
ORCID: Andresen, Thomas L.
Venue: Progress in Lipid Research
Publisher: Elsevier BV
Published: 2005-01
Volume: 44
Issue: 1
Pages: 68-97
ISSN: 0163-7827 (ISSN-L)
DOI: 10.1016/j.plipres.2004.12.001
OpenAlex: W2065946609
Cited by: 580
References: 260
Citations by year: 2026: 3 · 2025: 12 · 2024: 14 · 2023: 16 · 2022: 10 · 2021: 15 · 2020: 21 · 2019: 22 · 2018: 25 · 2017: 46 · 2016: 42 · 2015: 46 · 2014: 37 · 2013: 32 · 2012: 43
FWCI: 1.81
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Progress in Lipid Research (publishedVersion)
PubMed (publishedVersion)
Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion)
Topics: Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Physical Sciences › Engineering › Biomedical Engineering › Ultrasound and Hyperthermia Applications
Keywords: liposomal drug delivery, tumor-specific drug release, triggered drug release, secretory phospholipase A2, thermosensitive liposomes, cancer chemotherapy
MeSH terms: Antibodies, Antineoplastic Agents, Carrier Proteins, Cells, Hemolysis, Humans, Liposomes, Neoplasms, Phospholipases A, Prodrugs, Receptors, Cell Surface, Integrins, Drug Delivery Systems, Lipid Metabolism, Phospholipases A2, Folate Receptors, GPI-Anchored

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Advanced strategies in liposomal cancer therapy: Problems and prospects of active and tumor specific drug release

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks